Effects of Biofeedback-Guided Training on Muscle Strength and Postural Alignment in Upper Cross Syndrome.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 11, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special type of training called biofeedback-guided training compares to regular therapy in helping adults with Upper Cross Syndrome (UCS). UCS is a condition that causes muscle weakness and poor posture, especially in the neck and upper back, often leading to chronic neck pain and a forward head position. The study aims to see if biofeedback, which uses visual or audio signals to help people control their muscle activity, can improve muscle strength and posture better than conventional therapy.
Adults between 25 and 45 years old who have specific signs of UCS—like weak neck muscles, limited neck movement, a forward head posture, increased rounding of the upper back, and neck pain lasting more than three months—may be eligible to join. Participants will be split into two groups; one will receive biofeedback training, and the other will get regular therapy. Both groups will attend 12 sessions over 4 weeks. The researchers will check muscle strength and posture before, during, and after the treatment period to see which method works best. This study has not started recruiting yet, and people with recent neck surgery, neurological problems, or other treatments for UCS won’t be able to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Adults aged 25-45 years with both genders.
- * Individuals meeting the following diagnostic criteria for upper cross syndrome will be included:
- • Reduced strength of deep cervical flexors = unable to maintain pressure beyond 22-24 mm Hg (assessed via cranio-cervical flexion test).
- • Limited cervical range of motion (Flexion: \< 80 degrees, Extension: \< 70 degrees, Rotation: \< 90 degrees on both sides, Lateral Flexion: \< 20 degrees)
- • Postural deviations: forward head posture (CVA \<50 degrees), increased thoracic kyphosis (via flexi curve \>45 degrees).
- • Neck pain with a duration of over 3 months
- Exclusion Criteria:
- • • History of recent neck surgery or injury.
- • Patients with neurological disorders affecting muscle tone.
- • Involvement in other physical therapy programs focused on UCS.
- • Diagnosed musculoskeletal condition that could impact muscle performance.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
Aisha Razzaq, PHD*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported